Chiral N-substituted allylic amine compounds

US10179330B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10179330-B2
Application numberUS-201715469654-A
CountryUS
Kind codeB2
Filing dateMar 27, 2017
Priority dateJun 20, 2016
Publication dateJan 15, 2019
Grant dateJan 15, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The method relates to the field of asymmetric allylic amination and comprises preparing a chiral N-substituted allylic amine compound from the corresponding allylic substrates and substituted hydroxylamines, in the presence of a catalyst, said catalyst comprising copper compounds and a chiral ligand. Examples of chiral amine compounds which can be made using the method include Vigabatrin, Ezetimibe Terbinafine, Naftifine 3-methylmorphine, Sertraline, Cinacalcet, Mefloquine hydrochloride, and Rivastigmine. There are over 20,000 known bioactive molecules with chiral N-substituted allylic amine substructure. The method may also be used to produce non-natural chiral β-aminoacid esters, a sub-class of chiral N-substituted allylic amine compounds. Examples of β-aminoacid ester which can be produced by the disclosed method, include, but are not limited to, N-(2-methylpent-1-en-3-yl)benzenamine and Ethyl 2-methylene-3-(phenylamino)butanoate. Further, the products of the method described herein can be used to produce chiral heterocycles and bioactive molecules or materials. A novel chiral copper-ligand nitrosoarene complex is also set forth.

First claim

Opening claim text (preview).

The invention claimed is: 1. An isolated chemical compound having the formula [Cu(Ligand)2(ArNO)2]X2, wherein X is selected from a group consisting of halides, triflates, sulfates, acetates, and PF6. 2. The chemical compound of claim 1 wherein the compound is a chiral copper-nitrosoarene complex having two nitrogen donor ligands and two counter ions. 3. The chemical compound of claim 1 wherein the copper atom is bonded to two chiral nitrogen-donor ligands selected from the group comprising BINAM and NOBIN. 4. The chemical compound of claim 1 wherein the copper atom is bonded to a nitrosobenzene.

Assignees

Inventors

Classifications

  • At least one oxygen and one nitrogen atom present as complexing atoms in an at least bidentate or bridging ligand · CPC title

  • Optical isomers · CPC title

  • by stereospecific synthesis · CPC title

  • N-alkylated amines · CPC title

  • C07C209/02Primary

    by substitution of hydrogen atoms by amino groups · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10179330B2 cover?
The method relates to the field of asymmetric allylic amination and comprises preparing a chiral N-substituted allylic amine compound from the corresponding allylic substrates and substituted hydroxylamines, in the presence of a catalyst, said catalyst comprising copper compounds and a chiral ligand. Examples of chiral amine compounds which can be made using the method include Vigabatrin, Ezeti…
Who is the assignee on this patent?
Univ Louisiana At Lafayette
What technology area does this patent fall under?
Primary CPC classification B01J31/2217. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Jan 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).